Provided by Tiger Trade Technology Pte. Ltd.

INmune Bio Inc

2.32
+0.16007.41%
Post-market: 2.30-0.0200-0.86%19:31 EDT
Volume:520.14K
Turnover:1.18M
Market Cap:64.39M
PE:-3.34
High:2.34
Open:2.22
Low:2.19
Close:2.16
52wk High:2.44
52wk Low:1.09
Shares:27.75M
Float Shares:23.19M
Volume Ratio:1.46
T/O Rate:2.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6937
EPS(LYR):-1.8600
ROE:-74.82%
ROA:-39.12%
PB:3.16
PE(LYR):-1.25

Loading ...

INmune Bio - Xpro1595 Shows Significant Treatment Effect in Full Mitt Population

THOMSON REUTERS
·
Jun 02

INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter Mri Biomarker in Phase 2 Mindful Alzheimer's Trial

THOMSON REUTERS
·
Jun 02

INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial

GlobeNewswire
·
Jun 02

INmune Bio publishes Phase 2 MINDFuL results for XPro in Alzheimer’s subgroup with inflammation

Reuters
·
May 15

INmune Bio Receives FDA Fast Track Designation for Xpro1595 in Early Alzheimer's Disease

THOMSON REUTERS
·
May 14

INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease

GlobeNewswire
·
May 14

INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point

GlobeNewswire
·
May 13

Analysts Have Conflicting Sentiments on These Healthcare Companies: Inmune Bio (INMB) and Joint (JYNT)

TIPRANKS
·
May 10

INmune Bio Q1 net loss narrows on lower R&D expenses

Reuters
·
May 08

INmune Bio Q1 EPS USD -0.2

THOMSON REUTERS
·
May 08

INmune Bio Q1 EPS $(0.20) Beats $(0.22) Estimate.

Benzinga Earnings
·
May 08

INmune Bio Inc. Announces First Quarter 2026 Results and Provides Business Update

GlobeNewswire
·
May 08

INmune Bio Inc expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
May 06

INmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases

GlobeNewswire
·
May 06

INmune Bio to report Q1 results, host conference call and webcast May 7

Reuters
·
Apr 30

INmune Bio Inc. to Report First Quarter 2026 Financial Results and Provide Corporate Update on Thursday, May 7th

GlobeNewswire
·
Apr 30

INmune Bio announces new preclinical data for INB03

TIPRANKS
·
Apr 16

INmune Bio reports AACR preclinical data for INB03 in HER2-positive breast cancer models

Reuters
·
Apr 16

INmune Bio Inc. Announces New Preclinical Data at Aacr 2026 Demonstrating Inb03 (Xpro1595) Overcomes Resistance and Reduces Metastases in Her2-Positive Breast Cancer Models

THOMSON REUTERS
·
Apr 16

INmune Bio Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Mar 31